SYDNEY, Mar 2, 2022 - (ACN Newswire) - Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region.
Avance Clinical's CEO Yvonne Lungershausen said: "We continue to offer a hybrid working environment for our team however, they are increasingly wanting more in-office face-to-face time with colleagues and clients - while still having the flexibility of working remotely".
"Avance is continuing to experience significant growth facilitating our expansion into North Sydney with new offices to accommodate our growing team," she said.
Avance Clinical recently secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m.
"With the support of Riverside and its powerful global footprint and deep healthcare experience, Avance Clinical will execute on its regional and international expansion plans organically and via acquisitions," said Lungershausen.
Avance Clinical is the Australian-owned CRO that provides global regulatory standard clinical research services across all phases to the local and international biopharma industry.
The company is also accredited as a gene technology CRO under the Office of the Gene Technology Regulator (OGTR) which has allowed it to expand into clinical trials for vaccines and GMO therapies.
"We have shown, with our high growth and industry-leading repeat business rates that our focus on gold standard technology paired with solution-orientated clinical experts is the mix our biopharma clients require in this fast-moving, competitive and high-stakes sector," said Lungershausen.
Avance Clinical has been recognised for the past two consecutive years with the prestigious Frost & Sullivan CRO Best Practices Award.
Avance Clinical is the largest premium full-service Australian CRO delivering quality clinical trials, with globally accepted data, in Australia and New Zealand for international biotechs. The company's clients are biotechs in their early phases of drug development that need fast, agile, and adaptive solution-oriented clinical research services.
Frost & Sullivan awards Avance Clinical, a Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient for the past two years, has been providing CRO services in the region for 24 years.
Pre-clinical through to Phase 1 and 2 Avance Clinical offers pre-clinical services with their experienced ClinicReady team right through to Phase 1 and 2 clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes.
With experience across more than 105 indications, the CRO can deliver world-class results and high-quality internationally accepted data for FDA and EMA review.
Technology Avance Clinical uses state-of-the-art technology and gold standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comAvance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region.
Ukrainian esports holding company WePlay Holding announced this weekend it has terminated all partnership agreements with companies from Russia and Belarus amidst Russia’s ongoing invasion of Ukraine. WePlay also announced it would not organise Russian-language broadcasting for the upcoming Gamers Galaxy: Dota 2 Invitational Series Dubai 2022, instead opening up the event to community casting. […]
Ukrainian esports organisation , WePlay esports announced today that they will be ending all contracts with partners from the Russian federation. The decision was made after Russia decided to invade Ukraine in a military operation in the wee hours of Wednesday morning. Since then over a hundred casualties of Ukrainian citizens have been reported in […]
After the invasion of Ukraine by the Russian army, things have taken a turn for the worse and everything has been thrown into a frenzy. Reports of a full-fledged invasion of Ukraine by Russia surfaced after Russian president Vladimir Putin announced that the Russian Army will carry out a ‘military operation’ in Ukraine. Videos and […]
Google once used the slogan "don't be evil" to distinguish itself from its competitors, but now a growing number of pro-privacy startups are rallying to the mantra "don't be Google".
They are taking on Google Analytics, a product used by more than half of the world's websites to understand people's browsing habits.
The Russian Interior Ministry has taken down four major DarkWeb sites. The DarkWeb sites specialize in selling stolen payment card details from retailers and payment companies. Cybercriminals use these stolen cards to buy wares online and sell them for cash. This modus operandi is known as ‘Carding.’ Stolen Credit Card Market –A dying market An
Historically, Database Management systems (DBMS) were simple software programs and associated hardware that allowed users to access data from different geographical locations. The system offers its users the ability to store data without concerns about structural changes, or the data’s physical location. Additionally, a Database Management system (DBMS) can set restrictions on the data being […]
Long-distance investing may sound like an impossible feat to achieve for many investors. What if something goes wrong in the house? What if something needs fixing? What if there are […]
They left in droves. Over 40 million employees quit their jobs in 2021. The mass exodus of workers accelerated last year and shows no signs of slowing down in 2022. While this trend might look bad for the job market, it’s good news for technological development. The Great Resignation is already fast-forwarding